50%
of eligible cancer patients miss out on target therapies
from traditional tissue profiling approaches [1].
Rapid TissueMARK is a tissue test that detects over 50
NCCN-recommended actionable biomarkers with a fast turnaround time.
Available internationally outside the USA.
Rapid TissueMARK detects
1 in 6
additional biomarkers than conventional NGS [1] in
5 working days.
Cancers covered:
-
Lung
-
Breast and ovarian
-
Colon
-
Pancreas and Bile Duct
-
Prostate
Download the brochure for list of sub-panel genes and FDA-approved matched therapy by cancer type.
Downloads
Specifications
Single Nucleotide Variants (SNVs)
100%
Sensitivity
100%
Specificity
0.9%
LOD
Insertions / Deletions (indels)
100%
Sensitivity
100%
Specificity
1.5%
LOD
RNA Fusions
100%
Sensitivity
100%
Specificity
10 copies
LOD
Results tested at the stated mutant allele frequencies using reference standards, and FFPE clinical samples.
References:
-
Data on file - Comparing 0.9% versus conventional 5% threshold.